Axonics, Inc. (AXNX)
Data as of , from SEC Form 4 filings.
See up to 3 months of AXNX. The 7-day demo opens the 1M and 3M ranges and puts AXNX on your watchlist.
Start 7-day demoLatest AXNX insider trades
About Axonics, Inc. (AXNX)
Axonics, Inc. files with the SEC under CIK 0001603756 and is classified as surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site.
AXNX Form 4 activity by transaction type, last 90 days
No Form 4 activity for AXNX in the last 90 days.
AXNX insider transactions (Form 4)
4214 Form 4 filings on record, the earliest from Oct 3, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| John Woock - Officer | Derivative | Common Stock | 77,403 | $71.00 | $5.50M | |
| John Woock - Officer | Derivative | Performance-Based Restricted Stock Units | 13,125 | $0.00 | - | |
| John Woock - Officer | Derivative | Stock Options (Right to buy) | 15,555 | $56.81 | $884K | |
| John Woock - Officer | Derivative | Stock Options (Right to buy) | 3,581 | $45.18 | $162K | |
| Nancy Lynn Md Snyderman | Derivative | Common Stock | 14,944 | $71.00 | $1.06M | |
| Nancy Lynn Md Snyderman | Derivative | Stock Option (Right to Buy) | 4,167 | $36.90 | $154K | |
| Nancy Lynn Md Snyderman | Derivative | Stock Option (Right to Buy) | 10,000 | $49.96 | $500K | |
| Rinda Sama - Officer | Derivative | Common Stock | 83,854 | $71.00 | $5.95M | |
| Rinda Sama - Officer | Derivative | Common Stock | 608 | $71.00 | $43K | |
| Rinda Sama - Officer | Derivative | Performance-Based Restricted Stock Units | 13,125 | $0.00 | - | |
| Rinda Sama - Officer | Derivative | Stock Options (Right to buy) | 11,019 | $56.81 | $626K | |
| Rinda Sama - Officer | Derivative | Stock Options (Right to buy) | 9,962 | $45.18 | $450K | |
| Rinda Sama - Officer | Derivative | Stock Option (Right to Buy) | 6,294 | $69.37 | $437K | |
| Karen Noblett - Officer | Derivative | Common Stock | 34,428 | $71.00 | $2.44M | |
| Karen Noblett - Officer | Derivative | Performance-Based Restricted Stock Units | 7,500 | $0.00 | - | |
| Karen Noblett - Officer | Derivative | Stock Option (Right to Buy) | 2,963 | $56.81 | $168K | |
| Karen Noblett - Officer | Derivative | Stock Options (Right to buy) | 6,348 | $45.18 | $287K | |
| Karen Noblett - Officer | Derivative | Stock Option (Right to Buy) | 11,998 | $69.37 | $832K | |
| Esteban Lopez | Derivative | Common Stock | 6,600 | $71.00 | $469K | |
| Esteban Lopez | Derivative | Stock Options (Right to buy) | 10,000 | $11.30 | $113K | |
| Kari Leigh Keese - Officer | Derivative | Common Stock | 40,362 | $71.00 | $2.87M | |
| Kari Leigh Keese - Officer | Derivative | Performance-Based Restricted Stock Units | 3,125 | $0.00 | - | |
| David M. Demski | Derivative | Common Stock | 9,542 | $71.00 | $677K | |
| David M. Demski | Derivative | Stock Options (Right to buy) | 10,000 | $19.30 | $193K | |
| Robert McNamara | Derivative | Common Stock | 14,861 | $71.00 | $1.06M | |
| Robert McNamara | Derivative | Stock Option (Right to Buy) | 10,000 | $36.90 | $369K | |
| Robert McNamara | Derivative | Stock Option (Right to Buy) | 3,333 | $33.85 | $113K | |
| Robert McNamara | Derivative | Stock Option (Right to Buy) | 5,000 | $56.20 | $281K | |
| Jane E. Kiernan | Derivative | Common Stock | 19,861 | $71.00 | $1.41M | |
| Alfred J. Ford Jr. - Officer | Derivative | Common Stock | 43,450 | $71.00 | $3.08M | |
| Alfred J. Ford Jr. - Officer | Derivative | Performance-Based Restricted Stock Units | 11,250 | $0.00 | - | |
| Alfred J. Ford Jr. - Officer | Derivative | Stock Option (Right to Buy) | 4,655 | $45.18 | $210K | |
 Raymond W. Cohen - Officer | Derivative | Common Stock | 292,731 | $71.00 | $20.78M | |
| Raymond W. Cohen - Officer | Derivative | Performance-Based Restricted Stock Units | 31,125 | $0.00 | - | |
| Raymond W. Cohen - Officer | Derivative | Stock Option (Right to Buy) | 196,451 | $56.81 | $11.16M | |
| Raymond W. Cohen - Officer | Derivative | Stock Option (Right to Buy) | 106,776 | $69.37 | $7.41M | |
 Michael H. Carrel | Derivative | Common Stock | 17,861 | $71.00 | $1.27M | |
| Michael H. Carrel | Derivative | Stock Option (Right to Buy) | 5,000 | $36.90 | $185K | |
| Michael H. Carrel | Derivative | Stock Option (Right to Buy) | 10,000 | $50.15 | $502K | |
| Nancy Lynn Md Snyderman | Gift | Common Stock | 5,000 | $0.00 | - | |
| Kari Leigh Keese - Officer | Open-market sale | Common Stock | 364 | $69.40 | $25K | |
| Kari Leigh Keese - Officer | Open-market sale | Common Stock | 2,597 | $69.41 | $180K |
AXNX insider trading FAQ
What is the latest insider trade for AXNX?
Axonics, Inc. (AXNX) has filed no insider reports in the last 90 days. The most recent on record is dated 2024-11-15. The full record for AXNX runs to 14 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AXNX stock?
No insider purchases of AXNX were filed in the last 90 days.
How many insiders are selling AXNX stock?
No insider sales of AXNX were filed in the last 90 days. 2 sales are on record for this company.
Where can I see AXNX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AXNX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - John Woock view on EDGAR
- - Nancy Lynn Md Snyderman view on EDGAR
- - Rinda Sama view on EDGAR
- - Karen Noblett view on EDGAR
- - Esteban Lopez view on EDGAR
- - Kari Leigh Keese view on EDGAR
- - David M. Demski view on EDGAR
- - Robert McNamara view on EDGAR
- - Jane E. Kiernan
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where AXNX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AXNX with a 7-day demo
- AXNX on your watchlist
- Every AXNX Form 4 filing on record
- Up to 3 months of AXNX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
